TY - JOUR
T1 - Elevated free fatty acids impair glucose metabolism in women
T2 - Decreased stimulation of muscle glucose uptake and suppression of splanchnic glucose production during combined hyperinsulinemia and hyperglycemia
AU - Shah, Pankaj
AU - Vella, Adrian
AU - Basu, Ananda
AU - Basu, Rita
AU - Adkins, Aron
AU - Frederick Schwenk, W.
AU - Johnson, C. Michael
AU - Sreekumaran Nair, K.
AU - Jensen, Michael D.
AU - Rizza, Robert A.
PY - 2003/1/1
Y1 - 2003/1/1
N2 - The present study sought to determine whether elevated plasma free fatty acids (FFAs) alter the splanchnic and muscle glucose metabolism in women. To do so, FFAs were increased in seven women by an 8-h Intralipid/heparin (IL/hep) infusion, and the results were compared with those observed in nine women who were infused with glycerol alone. Glucose was clamped at ∼8.3 mmol/l and insulin was increased to ∼300 pmol/l to stimulate both muscle and hepatic glucose uptake. Insulin secretion was inhibited with somatostatin. Leg and splanchnic glucose metabolism were assessed using a combined catheter and tracer dilution approach. The glucose infusion rates required to maintain target plasma glucose concentrations were lower (P < 0.01) during IL/hep than glycerol infusion (30.8 ± 2.6 vs. 65.0 ± 7.9 μmol · kg-1 · min-1). Whole-body glucose disappearance (37.0 ± 2.2 vs. 70.9 ± 8.7 μmol · kg-1 · min-1; P < 0.001) and leg glucose uptake (24.3 ± 4.2 vs. 59.6 ± 10.0 μmol · kg fat-free mass of the leg-1 · min-1; P < 0.02) were also lower, whereas splanchnic glucose production (8.2 ± 0.8 vs. 4.3 ± 0.7 μmol · kg-1 · min-1; P < 0.01) was higher during IL/hep than glycerol infusion. We conclude that in the presence of combined hyperinsulinemia and hyperglycemia, elevated FFAs impair glucose metabolism in women by inhibiting whole-body glucose disposal, muscle glucose uptake, and suppression of splanchnic glucose production.
AB - The present study sought to determine whether elevated plasma free fatty acids (FFAs) alter the splanchnic and muscle glucose metabolism in women. To do so, FFAs were increased in seven women by an 8-h Intralipid/heparin (IL/hep) infusion, and the results were compared with those observed in nine women who were infused with glycerol alone. Glucose was clamped at ∼8.3 mmol/l and insulin was increased to ∼300 pmol/l to stimulate both muscle and hepatic glucose uptake. Insulin secretion was inhibited with somatostatin. Leg and splanchnic glucose metabolism were assessed using a combined catheter and tracer dilution approach. The glucose infusion rates required to maintain target plasma glucose concentrations were lower (P < 0.01) during IL/hep than glycerol infusion (30.8 ± 2.6 vs. 65.0 ± 7.9 μmol · kg-1 · min-1). Whole-body glucose disappearance (37.0 ± 2.2 vs. 70.9 ± 8.7 μmol · kg-1 · min-1; P < 0.001) and leg glucose uptake (24.3 ± 4.2 vs. 59.6 ± 10.0 μmol · kg fat-free mass of the leg-1 · min-1; P < 0.02) were also lower, whereas splanchnic glucose production (8.2 ± 0.8 vs. 4.3 ± 0.7 μmol · kg-1 · min-1; P < 0.01) was higher during IL/hep than glycerol infusion. We conclude that in the presence of combined hyperinsulinemia and hyperglycemia, elevated FFAs impair glucose metabolism in women by inhibiting whole-body glucose disposal, muscle glucose uptake, and suppression of splanchnic glucose production.
UR - http://www.scopus.com/inward/record.url?scp=0037223317&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037223317&partnerID=8YFLogxK
U2 - 10.2337/diabetes.52.1.38
DO - 10.2337/diabetes.52.1.38
M3 - Article
C2 - 12502491
AN - SCOPUS:0037223317
SN - 0012-1797
VL - 52
SP - 38
EP - 42
JO - Diabetes
JF - Diabetes
IS - 1
ER -